CLINICAL_TRIALS
trial_result
· 2012-12-17
Clinical Trial Update: Nepafenac 0.3% Two Study [Phase 2]
Summary
Two Phase 2 studies of nepafenac 0.3% for cataract have completed, and results were posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Alcon Research | Conditions: Cataract | Phase 2 | Status: COMPLETED | Results posted: 2012-12-17